Dallas, TX -- (SBWIRE) -- 05/02/2014 -- The "Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] – Global Forecast to 2017"analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia and Rest of World.
Browse 87 market data tables with 25 figures spread through 350 pages and in-depth TOC on "Next Generation Sequencing (NGS)".
http://www.marketsandmarkets.com/Market-Reports/next-generation-sequencing-ngs-technologies-market-546.html
Early buyers will receive 10% customization on reports.
The global NGS market was valued at $1.3 billion in 2012 and is poised to reach $2.7 billion by 2017 at a CAGR of 16.3%. The growth of the overall NGS market is driven by continuous innovations and developments in the market aimed at higher throughput, increased accuracy, and affordable costs. The opportunities for the growth of this market include developments in pre-sequencing, cloud computing, and NGS bioinformatics solutions.
Sample Request: http://www.marketsandmarkets.com/requestsample.asp?id=546
This research report categorizes and analyzes the global NGS market on the basis of steps in the NGS workflow, NGS technologies, and NGS applications. All these markets are further divided into segments and sub-segments, to provide exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Based on the NGS workflow, NGS pre-sequencing, sequencing and data analysis form the overall NGS market. Under pre-sequencing, the solutions for sample preparation are covered. The sequencing market covers platforms, reagents and services from key players like Illumina (U.S.), Life Technologies (U.S.), 454 Roche (U.S.), and Pacific Biosciences (U.S.). The market for sequencing platforms has been very dynamic. Some revolutionary platforms like GA IIx (Illumina) and SOLiD Series (Life Technologies) will take a setback and newer platforms like MiSeq and Ion Torrent Proton will gain market dominance.
Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=546
The NGS platforms market is a consolidated one and was dominated by Illumina in 2012, which accounted for the largest market share of more than 50%. Other companies with commercial platforms include Life Technologies (U.S.), 454 Roche (U.S.), and Pacific Biosciences (U.S.). The NGS bioinformatics/data analysis market is highly fragmented with key players like CLC bio (Denmark), Biomatters (New Zealand), Partek (U.S.), Genomatix (Germany), Knome (U.S.) and DNASTAR (U.S.) dominating this market space.
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets